Rob Guite is a partner in the Business Trial Practice Group in the firm's San Francisco office.
Areas of Practice
Mr. Guite focuses his litigation practice on class actions, involving ERISA, insurance, false advertising, commercial, construction and products liability matters. He regularly represents employers/plan sponsors, plan administrators and insurers in ERISA and fiduciary litigation involving health and welfare benefits, retirement benefits and compensation plans defending claims brought by individual participants or beneficiaries. In addition, Mr. Guite focuses his practice in defending food and beverage clients and retailers in class actions involving allegations of unfair competition and false advertising. He has extensive experience litigating cases involving business torts, bad faith, contracts, construction disputes, trade secrets, products liability and mass torts. Mr. Guite is admitted to practice in California, Montana and Washington and regularly represents clients in those jurisdictions.
Mr. Guite is co-editor of the LexisNexis Practice Guide: Washington Contract Litigation (2016) and the author of LexisNexis Practice Advisor articles on Trade Secret Misappropriation: Elements, Remedies and Defenses and False Statements, Defamation and Trade Libel. He is co-author of "DOL Final Fee Disclosure Rules May Have Consequences for Fiduciaries Beyond Fines - Could Result in Increased Litigation and Government Enforcement," appearing in Bloomberg BNA's Pensions & Benefits Daily, "ERISA Fiduciary Claims: Planning, Protecting and Preparing for Class Actions," appearing in the Employee Relations Law Journal. Mr. Guite has received an AV® rating by Martindale-Hubbell®, the highest rating an attorney can receive for legal quality and ethics. He is a member of the Board of Bar Examiners of the Washington State Bar Association.
Mr. Guite is a Co-Chair of the San Francisco Recruiting Committee and Co-Chair of the firm's Out at Sheppard LGBTQ Group.
More Legal and Business Bylines From Robert J. Guite
- FDA Boosts Protein Preemption Defense - (Posted On Thursday, February 17, 2022)
- Cannabis Legislation Year-in-Review - (Posted On Tuesday, January 04, 2022)
- Are Flavor Cases Fizzling? Two More Courts Grant Motions to Dismiss - (Posted On Tuesday, November 16, 2021)
- It’s Not Pop Secret, Ninth Circuit Affirms that Plaintiff Didn’t Have a Leg to Stand On - (Posted On Friday, December 11, 2020)
- “Happy Cows” False Labeling Theory is Just “Half Baked”: Court Dismisses False Advertising Claims Against Ben & Jerry’s - (Posted On Tuesday, May 12, 2020)
- CBD Industry Beware: The False Labeling Class Action Has Arrived - (Posted On Monday, September 30, 2019)
- Lack of Standing Dooms Organizational Plaintiffs’ False Advertising Claims; Such a Challenge Can Be Brought at Any Time - (Posted On Tuesday, August 06, 2019)
- Ninth Circuit Confirms Plaintiffs Are Not Required to Undermine Defendant’s Evidence to Withstand Summary Judgment in False Labeling Class Actions - (Posted On Tuesday, January 15, 2019)
- Ninth Circuit Panel Affirms Inadmissibility Alone is Not a Proper Basis to Reject Evidence in Support of Class Certification - (Posted On Thursday, November 29, 2018)
- “I’ll Be Back;” Ninth Circuit Gives Arnold Schwarzenegger-Branded Supplement Purchasers Another Shot to Pursue UCL, FAL, CLRA and Warranty Claims - (Posted On Thursday, October 18, 2018)